Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Deutsche Bank bolsters U.S. healthcare IB unit with new exec hires

Published 08/10/2021, 02:58 PM
Updated 08/10/2021, 03:04 PM
© Reuters. The logo of Deutsche Bank is seen at its headquarters ahead of the bank's annual general meeting in Frankfurt, Germany May 18, 2017.  REUTERS/Ralph Orlowski/Files

(Reuters) - Deutsche Bank AG (NYSE:DB) has hired two new managing directors for its healthcare investment banking team in the United States, according to an internal memo seen by Reuters, as the bank looks to double down on healthcare dealmaking.

Spencer Watts and Helen Oesch, both veterans in the sector, will join the bank from Nomura Holdings (NYSE:NMR) Inc and Bank of Montreal, respectively. They will be based in New York.

"We've been building out our coverage and capabilities, by hiring senior bankers to strengthen our existing presence in U.S. Healthcare Services (NASDAQ:HCSG) & Technology," Nick Richitt, the lender's global co-head of healthcare investment banking, said in the memo on Tuesday.

Deutsche has made 10 new hires in the division so far this year, including the appointment of Priyanka Verma, an industry expert who has worked with clients including Thermo Fisher (NYSE:TMO) and KKR & Co (NYSE:KKR), as managing director.

Watts, who is joining this month, has previously held roles in the healthcare investment banking division of UBS Group AG (SIX:UBSG), according to his LinkedIn profile.

Oesch is set to join in October and was earlier a director at Credit Suisse (SIX:CSGN) for nearly eight years.

The new appointees will report to Richitt.

Deutsche will also hire three associates for the unit who will join over the next few weeks, the bank said.

In recent months, the bank underwrote the initial public offering of Signify Health Inc and advised on the $1.1 billion blank-check deal of mobile medical services provider DocGo.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In June, the bank also worked on the $7 billion merger between health data firms Datavant and Ciox Health.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.